Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 57,675 | 84,513 | 75,743 | 68,791 | 45,599 |
| Cost of Goods | 20,879 | 22,893 | 30,775 | 32,084 | 14,594 |
| Gross Profit | 36,796 | 61,620 | 44,968 | 36,707 | 31,005 |
| Operating Expenses | 148,054 | 204,855 | 249,307 | 225,332 | 125,869 |
| Operating Income | -110,379 | -142,342 | -203,564 | -188,541 | -94,270 |
| Interest Expense | 13,527 | 15,315 | 13,642 | 15,308 | 15,326 |
| Other Income | 3,363 | 4,024 | 3,742 | 39,496 | 6,747 |
| Pre-tax Income | -120,543 | -153,633 | -213,464 | -164,353 | -102,849 |
| Income Tax | 312 | 521 | 449 | 473 | 136 |
| Net Income Continuous | -120,855 | -154,154 | -213,913 | -164,826 | -102,985 |
| Minority Interests | -74,858 | -93,517 | -127,338 | -100,123 | -56,459 |
| Net Income | $-45,997 | $-60,637 | $-86,575 | $-64,703 | $-46,526 |
| EPS Basic Total Ops | -2.69 | -8.47 | -15.97 | -11.84 | -9.75 |
| EPS Basic Continuous Ops | -5.81 | -19.01 | -36.10 | -30.25 | -21.44 |
| EPS Diluted Total Ops | -2.69 | -8.47 | -15.97 | -11.84 | -9.75 |
| EPS Diluted Continuous Ops | -5.81 | -19.01 | -36.10 | -30.25 | -21.44 |
| EPS Diluted Before Non-Recurring Items | -2.69 | -8.47 | -14.54 | -11.84 | -9.75 |
| EBITDA(a) | $-101,015 | $-131,235 | $-192,146 | $-177,836 | $-83,323 |